Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Yanagisawa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|November 17, 2025
Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesotheliomaAsako Yanagisawa, Takumi Fukaya, Kento Noda, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Crizotinib-induced Rectal Perforation with AbscessAsako Yanagisawa, Noriko Hayama, Hiroyuki Amano, et al.
Acute Medicine & Surgery|November 11, 2017
A case of cerebral tuberculoma mimicking neurocysticercosisHiroko Yuzawa, Yousuke Hirose, Tomonori Kimura, et al.
Internal Medicine (Tokyo, Japan)|February 14, 2018
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial PneumoniasTetsuo Fujita, Takuma Hiroishi, Kohei Shikano, et al.
Chinese Clinical Oncology|January 8, 2017
A prospective, multicenter phase II trial of low-dose erlotinib as maintenance treatment after platinum doublet chemotherapy for advanced non-small cell lung cancer harboring EGFR mutationSatoshi Hirano, Go Naka, Yuichiro Takeda, et al.
International Journal of Molecular Medicine|March 22, 2022
Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysinTakayuki Kobayashi, Jun-Dal Kim, Akira Naito, et al.
Case Reports in Oncological Medicine|February 16, 2018
Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LARAsako Yanagisawa, Satoshi Hirano, Shinichiro Shimizu, et al.
BMC Pulmonary Medicine|December 10, 2021
Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairmentAsako Yanagisawa, Akira Naito, Takayuki Jujo-Sanada, et al.
Pulmonary Circulation|September 14, 2020
Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat modelTakayuki J Sanada, Koji Hosomi, Hiroki Shoji, et al.
Scientific Reports|November 7, 2024
Deciphering the inhibitory effects of trimetazidine on pulmonary hypertension development via decreasing fatty acid oxidation and promoting glucose oxidationAsako Yanagisawa, Jun-Dal Kim, Akira Naito, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|November 17, 2025
Case Report: IL-6 suppression: a potential strategy for mitigating severe immune-related adverse events in nivolumab and ipilimumab therapy for malignant pleural mesotheliomaAsako Yanagisawa, Takumi Fukaya, Kento Noda, et al.
Internal Medicine (Tokyo, Japan)|October 13, 2017
Crizotinib-induced Rectal Perforation with AbscessAsako Yanagisawa, Noriko Hayama, Hiroyuki Amano, et al.
Acute Medicine & Surgery|November 11, 2017
A case of cerebral tuberculoma mimicking neurocysticercosisHiroko Yuzawa, Yousuke Hirose, Tomonori Kimura, et al.
Internal Medicine (Tokyo, Japan)|February 14, 2018
The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial PneumoniasTetsuo Fujita, Takuma Hiroishi, Kohei Shikano, et al.
Chinese Clinical Oncology|January 8, 2017
A prospective, multicenter phase II trial of low-dose erlotinib as maintenance treatment after platinum doublet chemotherapy for advanced non-small cell lung cancer harboring EGFR mutationSatoshi Hirano, Go Naka, Yuichiro Takeda, et al.
International Journal of Molecular Medicine|March 22, 2022
Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysinTakayuki Kobayashi, Jun-Dal Kim, Akira Naito, et al.
Case Reports in Oncological Medicine|February 16, 2018
Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LARAsako Yanagisawa, Satoshi Hirano, Shinichiro Shimizu, et al.
BMC Pulmonary Medicine|December 10, 2021
Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairmentAsako Yanagisawa, Akira Naito, Takayuki Jujo-Sanada, et al.
Pulmonary Circulation|September 14, 2020
Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat modelTakayuki J Sanada, Koji Hosomi, Hiroki Shoji, et al.
Scientific Reports|November 7, 2024
Deciphering the inhibitory effects of trimetazidine on pulmonary hypertension development via decreasing fatty acid oxidation and promoting glucose oxidationAsako Yanagisawa, Jun-Dal Kim, Akira Naito, et al.
Pageof 2